CLASS II Drug recall · Reported 12 Dec 2012 · FDA Enforcement Report
Nutropin AQ NuSpin 20 (somatropin recalled by Genentech
Genentech is recalling Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ Genentech, South San, distributed nationwide in the US. The recall was initiated on 20 Sep 2012 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-087-2013
- FDA event ID
- 63243
- Recalling firm
- Genentech, South San Francisco, CA
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 20 Sep 2012
- FDA classified
- 4 Dec 2012
- Reported
- 12 Dec 2012
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Drug class
- Injectable & IV Drugs
Timeline
| 20 Sep 2012 | Recall initiated by company | |
| 4 Dec 2012 | Classified by FDA | +75 days |
| 12 Dec 2012 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin AQ NuSpin 10 & 20 reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).
Product as listed by the FDA
Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ 2mL Genentech, South San Francisco, CA 94080, NDC#50242-0076-01
Where it was distributed
Nationwide
Questions about this recall
Why was it recalled?
Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin AQ NuSpin 10 & 20 reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).
Which lots are affected?
Lot# 936674 Exp. 09/30/13
Where was it sold?
Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
1 other product · FDA event 63243| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Nutropin AQ NuSpin 10 (somatropin recalled by Genentech | Genentech | Other | Nationwide |
More recalls from Genentech
All 11| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Cathflo activase (Alteplase), 2mg vials recalled by GenentechCathflo Activase | Genentech | Sterility | Nationwide |
| Drug | CLASS III | Susvimo (ranibizumab injection), 100mg/mL recalled by GenentechSusvimo | Genentech | Other | Nationwide |
| Drug | CLASS II | Xolair (omalizumab) Injection, 150 mg/, 1 prefilled syringe recalledXolair | Genentech | Potency & Assay | Nationwide |
| Drug | CLASS III | Evrysdi (risdiplam) for oral solution, 60 mg recalled by Genentech | Genentech | Other | Nationwide |
| Drug | CLASS III | Klonopin (clonazepam) recalled by Genentech | Genentech | Other | Nationwide |